Celgene says patent-fighting hedge fund manager wants to short its shares
July 29, 2015 at 16:01 PM EDT
NEW YORK, July 29 (Reuters) - Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs.
